Search

Search Constraints

Start Over Filtering by: Keyword ERLOTINIB Remove constraint Keyword: ERLOTINIB

Search Results

  • Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO-Friends of Cancer Research Washout Period and Concomitant Medication Work Group
  • A Phase II Study of Telisotuzumab Vedotin in Patients With c-MET-positive Stage IV or Recurrent Squamous Cell Lung Cancer (LUNG-MAP Sub-study S1400K, NCT03574753)
  • Osimertinib Versus Comparator EGFR TKI as First-Line Treatment for EGFR-Mutated Advanced NSCLC: FLAURA China, A Randomized Study
  • An allosteric PGAM1 inhibitor effectively suppresses pancreatic ductal adenocarcinoma
  • Genomic Sequencing Procedure Microcosting Analysis and Health Economic Cost-Impact Analysis A Report of the Association for Molecular Pathology
  • Gefitinib Versus Placebo in Completely Resected Non-Small-Cell Lung Cancer: Results of the NCIC CTG BR19 Study
  • Overview of Thoracic Oncology Trials in Cooperative Groups Around the Globe
  • ALCHEMIST Trials: A Golden Opportunity to Transform Outcomes in Early-Stage Non-Small Cell Lung Cancer